Journal of Clinical Anesthesia · 1998 · 68 citations · 14 references
MedicineAnesthesiologyOrthopedic SurgeryAnesthesiaPain ManagementRegional AnesthesiaAnesthesia For Orthopedic SurgeryAnesthesia SafetyAnesthetic PharmacologyRegional Anesthesia For Abdominal SurgerySpinal AnesthesiaUpper Limb Nerve BlocksAnesthetic Drug SafetyNerve Block SafetyPropofol AnesthesiaPropofol UseRegional Anesthesia EffectsRemifentanil Infusion
STUDY OBJECTIVE: To compare the safety and efficacy of remifentanil and propofol as adjuncts to regional anesthesia in patients undergoing orthopedic or urogenital surgery. DESIGN: Prospective, randomized study. SETTING: Multicenter university hospitals. PATIENTS: 107 ASA physical status I, II, and III adult patients who underwent orthopedic or urogenital surgery with axillary, ankle, or spinal block. INTERVENTIONS: Patients were randomized to receive either an infusion of remifentanil 0.2 microg/kg/min or propofol 100 microg/kg/min 5 minutes before nerve block placement. The infusions were decreased by 50% on block completion, increased by 50% for patient discomfort, and decreased by 50% for hypoventilation (< 8 breaths/min) or hemodynamic instability. MEASUREMENTS AND MAIN RESULTS: Pain, discomfort, anxiety, and sedation were assessed by both patient and investigator. Vital signs and adverse events were recorded. Fewer patients in the remifentanil group experienced pain during block placement (6%), and were oversedated (7%) than patients in the propofol group (23% and 26%, respectively; p < 0.05). Hypoventilation during and after block placement (21% and 25%, respectively) and nausea and vomiting during and after block placement (60% and 21%, respectively) were more common in the remifentanil group than in the propofol group (0% and 3%; 17% and 6%, respectively; p < 0.05). The incidence of hypoventilation in remifentanil-treated patients was higher in patients over 65 years of age (p < 0.05), but was transient, resolving within minutes of discontinuing the infusion. CONCLUSIONS: At the doses studied, remifentanil was more effective than propofol in minimizing pain without producing excessive sedation. Remifentanil was associated with more transient respiratory depression and short-term nausea. Our findings indicate that the initial remifentanil rate should be 0.1 microg/kg/min (50% lower than the study's initial rate) and should be further decreased an additional 50% in the elderly to minimize adverse effects.
14
Validity and Reliability of the Observer??s
DORIS A. CHERNIK, Dennis B. Gillings, HARRIET LAINE et al. · Journal of Clinical Psychopharmacology · 1990 · 1.3K citations
A Postanesthetic Recovery Score
J. Antonio Aldrete, DIANE KROULIK · Anesthesia & Analgesia · 1970 · 1.1K citations
Veterinary Medicine, Anesthesiology, Perioperative Medicine +11
Preliminary Pharmacokinetics and Pharmacodynamics of an Ultra-Short-Acting Opioid
Peter S. A. Glass, David Hardman, Y Kamiyama et al. · Anesthesia & Analgesia · 1993 · 583 citations
Propofol: a new intravenous anesthetic.
Peter S. Sebel, Jane D. Lowdon · PubMed · 1989 · 519 citations